Caris Life Sciences, Inc.
CAI
Rang in aandelen
#2236
Caris Life Sciences, Inc. operates as a leading "TechBio" firm, harnessing... Caris Life Sciences, Inc. operates as a leading "TechBio" firm, harnessing artificial intelligence to deliver comprehensive molecular profiling services to clients both in the United States and internationally. The company is dedicated to transforming medical care by innovating and bringing to market advanced solutions that leverage molecular data and sophisticated machine learning algorithms. Its extensive suite of molecular diagnostic offerings includes MI Profile, a specialized solution analyzing tissue samples, and Caris Assure, a blood-based test designed for cancer treatment applications. Furthermore, Caris provides research and development support to biopharmaceutical customers, encompassing laboratory delivery, strategic data insights, and dedicated research initiatives. Established in 2008, the company maintains its corporate headquarters in Irving, Texas.
Aandeelprijs
$30.52
Marktkapitalisatie
$8.63B
Verandering (1 dag)
-5.65%
Verandering (1 jaar)
1.60%
Land
US
Handel Caris Life Sciences, Inc. (CAI)
Categorie
Healthcare
Koersgeschiedenis voor Caris Life Sciences, Inc. (CAI)
Hoogste slotkoers: $29.74 op 2026-10-01
Laagste slotkoers: $26.95 op 2025-06-01
Laagste slotkoers: $26.95 op 2025-06-01
Koersgeschiedenis van Caris Life Sciences, Inc. van 2025 tot 2026
Jaarlijkse koersprestatie
| Jaar | Prestaties |
|---|---|
| 2026 (TTM) | -17.62% |
| 2025 | 0.00% |
Aandelenkoers van vergelijkbare bedrijven of concurrenten
| Bedrijf | Aandelenkoers | Verandering 1jr% | Land |
|---|---|---|---|
| $536.47 | 25.80% |
US
|
|
| $187.21 | 597.24% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $291.76 | 2.51% |
BE
|
|
| $883.47 | 8.51% |
NL
|
